Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Eastman Kodak Company    EKDKQ

News SummaryMost relevantAll newsSector news 

WSJ BLOG/Health: A.M. Vitals: FDA Adds a Warning, Removes Another From Statin Labels

share with twitter share with LinkedIn share with facebook
share via e-mail
02/29/2012 | 03:13pm CET

(This story has been posted on The Wall Street Journal Online's Health Blog at http://blogs.wsj.com/health.)

By Katherine Hobson

The FDA and Statins: The FDA will require drug makers to add to statin labels a warning about a small increase in the risk of increased blood-sugar levels and of diabetes linked to the drugs, the WSJ reports. The labels will also include the information that some patients have experienced an adverse reaction of memory loss and confusion, though that won't be a full-fledged warning. But the FDA also removed a warning about the need for liver-enzyme monitoring from statin labels. Cardiologists tell the paper that most people should keep taking their statins despite the new label information.

Benefit Cuts at Kodak: Eastman Kodak is proposing to end health-care benefits for about 16,000 Medicare-eligible retirees in order to save about $20.5 million annually, the Associated Press reports. Kodak filed for Chapter 11 last month.

Insurer and Physicians' Group Clash: Insurer Blue Shield of California filed a demand for at least $10.5 million in damages from Monarch HealthCare, a physician association that sold its management arm to a unit of UnitedHealth Group, the WSJ reports. Blue Shield alleges that Monarch tried to direct Blue Shield members into competing health plans and that physicians stopped seeing some members, violating the contract between Blue Shield and Monarch. Monarch says it objects to "the mischaracterizations made by Blue Shield," the paper says. The case was submitted for binding arbitration.

The Right Dose of Selenium: A review of previously published research appearing in the Lancet suggests that large doses of selenium supplements could raise the risk for type 2 diabetes, Bloomberg News reports. The author of the review suggests that people with blood selenium levels of 122 micrograms per liter or higher shouldn't supplement with the mineral, which has been associated with a lower risk of some cancers, BN says.

Image: iStockphoto

 -For continuously updated news from The Wall Street Journal, see WSJ.com at http://wsj.com. 

Stocks mentioned in the article : Eastman Kodak Company
share with twitter share with LinkedIn share with facebook
share via e-mail
12/01 EASTMAN KODAK : Patent Issued for Manufacturing of High Resolution Conductive Pa..
12/01 EASTMAN KODAK : Kodak unveils enhancements to its CTP portfolio
11/27 EASTMAN KODAK : Kodak branch features the Heartland Series
11/25 EASTMAN KODAK : Solution provider EPM joins the ID Network
11/24 EASTMAN KODAK : Emaciated dog leads to cruelty charge
11/24 EASTMAN KODAK : Assigned Patent
11/22 EASTMAN KODAK : Trademark Application for "PLAYSPORT" Filed by Eastman Kodak Com..
11/22 EASTMAN KODAK : Closes the Sale of $200 Million of Series A Convertible Preferre..
11/18 EASTMAN KODAK CO : Change in Directors or Principal Officers (form 8-K)
11/16 EASTMAN KODAK CO : Entry into a Material Definitive Agreement, Termination of a ..
More news
Sector news : Photographic Equipment
11/23DJSamsung Offices Raided by South Korean Prosecutors
11/21DJFantastic Beasts' Takes Top Spot at Box Office
11/16DJSONY : October Internet Attack Targeted PlayStation Network, Researchers Say
11/15 PANASONIC : Israeli chipmaker TowerJazz sees brighter 2017 after record third-qu..
11/11DJFoxconn Profit Declines on Sharp Corp. Losses
More sector news : Photographic Equipment
Income Statement Evolution
More Financials
Jeff J. Clarke Chief Executive Officer & Director
James V. Continenza Chairman
David Bullwinkle Chief Financial Officer & Senior Vice President
Kim E. VanGelder Chief Information Officer & Senior Vice President
Terry R. Taber Chief Technology Officer & Senior Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
LARGAN PRECISION CO., ..--.--%15 345
GOPRO INC-44.59%1 380
TAMRON CO LTD-14.50%435
More Results